Skip to main content
VERA
NASDAQ Life Sciences

Vera Therapeutics Q3 Loss Narrower Than Expected at $93.7M

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$30.98
Mkt Cap
$2.172B
52W Low
$23.05
52W High
$56.05
52W Position info
34% above low
Off High info
45% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

VERA sits 34% above its 52-week low of $23.05.

Summary

Vera Therapeutics posted a Q3 net loss of $93.711 million, well narrower than the IBES estimate of -$117.1 million, and reported $10.3 million in Q3 product revenue. Operating loss came in at $95.702 million versus the -$119 million consensus, with operating expenses of $105.979 million. The beat follows the September ORIGIN 3 final efficacy readout, where TRUTAKNA met all prespecified endpoints, and comes as the company spends heavily to prepare for commercial launch. In late October the company drew $75 million under its debt facility, bringing pro forma cash and marketable securities to $459 million, with up to $350 million still available. The narrower-than-expected loss shows spending discipline relative to expectations while the launch build-out continues.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — Vera drew $75 million under its debt facility in late October, bringing pro forma cash and marketable securities to $459 million, with up to $350 million still available.

At the time of this announcement, VERA was trading at $30.98 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $23.05 to $56.05. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

VERA - Latest Insights

VERA
Nov 05, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $29.53
Real-time Price: $25.25 info
Change: -$4.28 (-14%) info
Market Cap: $1.84B info
VERA
Nov 05, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $31.07
Real-time Price: $25.25 info
Change: -$5.82 (-19%) info
Market Cap: $1.84B info
VERA
Sep 15, 2026, 6:45 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $38.64
Real-time Price: $25.25 info
Change: -$13.39 (-35%) info
Market Cap: $1.84B info
VERA
Sep 15, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $37.69
Real-time Price: $25.25 info
Change: -$12.44 (-33%) info
Market Cap: $1.84B info
VERA
Aug 10, 2026, 5:07 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $31.50
Real-time Price: $25.25 info
Change: -$6.25 (-20%) info
Market Cap: $1.84B info